Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Emerald Bioscience Inc (EMBI)

Emerald Bioscience Inc (EMBI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 40,206
  • Shares Outstanding, K 134,020
  • Annual Sales, $ 0 K
  • Annual Income, $ -19,190 K
  • 60-Month Beta 0.49
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.12
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/09/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2810 +3.20%
on 06/18/19
0.5979 -51.50%
on 06/05/19
-0.2400 (-45.28%)
since 05/24/19
3-Month
0.2810 +3.20%
on 06/18/19
1.1700 -75.21%
on 04/09/19
-0.3400 (-53.97%)
since 03/25/19
52-Week
0.0500 +480.00%
on 10/31/18
1.1700 -75.21%
on 04/09/19
+0.0085 (+3.02%)
since 06/25/18

Most Recent Stories

More News
Cannastocks2019 Investor Conference & Webinar Now Available for On-Demand Viewing

NEW YORK , May 17, 2019 /PRNewswire/ -- Virtual Investor Conferences, in partnership with Midtown Partners & Co, LLC, today announced that the presentations from the Cannastocks2019 Q1 Virtual...

KSHB : 4.4700 (+0.19%)
EMHTF : 1.7500 (-5.41%)
AXIM : 0.7750 (-3.13%)
CNPOF : 2.3500 (-6.00%)
OGRMF : 8.3500 (+4.64%)
OGI.VN : 7.980 (-3.51%)
EMBI : 0.2960 (-1.33%)
SRUTF : 0.5400 (+13.85%)
GSRX : 0.9700 (+2.11%)
SPRWF : 1.1491 (-1.79%)
SPR : 79.85 (-0.84%)
TGIF : N/A (unch)
TGIFF : 0.3380 (+0.54%)
MRMD : 2.1700 (-1.81%)
FIRE.TO : 1.50 (-1.32%)
EMH.VN : 2.310 (-5.33%)
ACRGF : 17.0600 (-12.11%)
Cannastocks2019 Live-Stream Investor Conference & Webinar May 15th

NEW YORK , May 14, 2019 /PRNewswire/ -- Virtual Investor Conferences, in partnership with Midtown Partners & Co, LLC, today announced the agenda for the upcoming Cannastocks2019 Q1 Virtual lnvestor...

KSHB : 4.4700 (+0.19%)
EMHTF : 1.7500 (-5.41%)
AXIM : 0.7750 (-3.13%)
CNPOF : 2.3500 (-6.00%)
OGRMF : 8.3500 (+4.64%)
OGI.VN : 7.980 (-3.51%)
EMBI : 0.2960 (-1.33%)
SRUTF : 0.5400 (+13.85%)
GSRX : 0.9700 (+2.11%)
SPRWF : 1.1491 (-1.79%)
SPR : 79.85 (-0.84%)
TGIF : N/A (unch)
TGIFF : 0.3380 (+0.54%)
MRMD : 2.1700 (-1.81%)
FIRE.TO : 1.50 (-1.32%)
EMH.VN : 2.310 (-5.33%)
ACRGF : 17.0600 (-12.11%)
Emerald Bioscience to Participate at the CannaStocks 2019 Q1 Investor Conference

via NEWMEDIAWIRE - Emerald Bioscience, Inc. (OTCQB: EMBI), focused on the development of cannabinoid-based therapeutics to address global medical indications, especially those of unmet medical need, announced...

OTCM : 34.8500 (+4.03%)
EMBI : 0.2960 (-1.33%)
Emerald Bioscience Announces Ophthalmology Scientific Advisory Board Members

via NEWMEDIAWIRE -- Emerald Bioscience, Inc. (OTCQB: EMBI), a biopharmaceutical company focused on bioengineered cannabinoid-based therapeutics to address global medical indications, today announced members...

EMBI : 0.2960 (-1.33%)
Emerald Bioscience to Present at the 2019 H.C. Wainwright Global Life Sciences Conference

via NEWMEDIAWIRE - Emerald Bioscience, Inc. (OTCQB: EMBI), a biopharmaceutical company focused on developing bioengineered cannabinoid-based therapeutics to address global medical indications, today announced...

EMBI : 0.2960 (-1.33%)
Emerald Bioscience, Inc. Announces DEA Decision that its Proprietary Cannabidiol Analog is not a Regulated Chemical or Controlled Substance Under Controlled Substances Act

via NEWMEDIAWIRE - Emerald Bioscience, Inc. (OTCQB: EMBI), a biopharmaceutical company focused on developing bioengineered cannabinoid-based therapeutics to address global medical indications, today announced...

EMBI : 0.2960 (-1.33%)
Nemus Bioscience, Inc. Changes Name to Emerald Bioscience, Inc. and Provides Update of Recent Research Accomplishments

NMUS : 0.6500 (-9.52%)
EMBI : 0.2960 (-1.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade EMBI with:

Key Turning Points

2nd Resistance Point 0.3233
1st Resistance Point 0.3117
Last Price 0.2960
1st Support Level 0.2867
2nd Support Level 0.2733

See More

52-Week High 1.1700
Fibonacci 61.8% 0.7422
Fibonacci 50% 0.6100
Fibonacci 38.2% 0.4778
Last Price 0.2960
52-Week Low 0.0500

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar